Profound Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Profound Medical Corp
PROF Stock  USD 8.22  0.12  1.44%   
Profound Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Profound Medical's valuation are provided below:
Gross Profit
10.4 M
Profit Margin
(2.75)
Market Capitalization
298.3 M
Enterprise Value Revenue
19.6743
Revenue
14.3 M
There are over one hundred nineteen available trending fundamental ratios for Profound Medical Corp, which can be analyzed over time and compared to other ratios. Active traders should verify all of Profound Medical Corp recent fundamental drivers against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. The Profound Medical's current Market Cap is estimated to increase to about 313.8 M. The Profound Medical's current Enterprise Value is estimated to increase to about 266.5 M

Profound Medical Total Revenue

12.28 Million

Check Profound Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Profound Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 M, Interest Expense of 737.9 K or Selling General Administrative of 27.9 M, as well as many indicators such as Price To Sales Ratio of 29.06, Dividend Yield of 0.0 or PTB Ratio of 3.89. Profound financial statements analysis is a perfect complement when working with Profound Medical Valuation or Volatility modules.
  
Build AI portfolio with Profound Stock
Check out the analysis of Profound Medical Correlation against competitors.

Profound Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets49 M80.8 M36.8 M
Slightly volatile
Short and Long Term Debt Total6.7 M5.9 M5.4 M
Slightly volatile
Total Current Liabilities5.3 M7.5 M3.9 M
Slightly volatile
Total Stockholder Equity38.9 M69.5 M29.6 M
Slightly volatile
Property Plant And Equipment Net1.4 M944.2 K991.3 K
Slightly volatile
Accounts Payable2.3 M1.5 M1.5 M
Slightly volatile
Cash34.9 M63.1 M26.7 M
Slightly volatile
Non Current Assets Total1.3 M1.3 M2.9 M
Slightly volatile
Cash And Short Term Investments35.6 M63.1 M27.1 M
Slightly volatile
Net Receivables4.1 M8.1 M3.4 M
Slightly volatile
Common Stock Total Equity255.4 M243.3 M119.1 M
Slightly volatile
Common Stock Shares Outstanding29.9 M28.5 M11.6 M
Slightly volatile
Liabilities And Stockholders Equity49 M80.8 M36.8 M
Slightly volatile
Non Current Liabilities Total5.1 M3.7 M4.1 M
Slightly volatile
Other Current Assets876.3 K1.5 M701.6 K
Slightly volatile
Other Stockholder Equity12.5 M24.5 M9.6 M
Slightly volatile
Total Liabilities10.1 M11.3 M7.2 M
Slightly volatile
Property Plant And Equipment Gross2.1 M3.7 M1.7 M
Slightly volatile
Total Current Assets44.6 M79.4 M33.8 M
Slightly volatile
Short Term Debt1.8 M2.3 M1.5 M
Slightly volatile
Intangible Assets223.2 K234.9 K885 K
Pretty Stable
Common Stock340 M323.8 M128.8 M
Slightly volatile
Other Liabilities1.1 M878.6 K726.8 K
Slightly volatile
Net Tangible Assets38 M59 M30.1 M
Slightly volatile
Long Term Debt5.7 M3.4 M5.4 M
Very volatile
Long Term Debt Total6.4 M10.2 M6.9 M
Slightly volatile
Capital Surpluse23.6 M22.5 M11.9 M
Slightly volatile
Short and Long Term Debt1.9 M1.6 M1.4 M
Slightly volatile
Property Plant Equipment1.7 M2 M1.2 M
Slightly volatile
Net Invested Capital56 M74.8 M38 M
Slightly volatile
Net Working Capital50 M71.9 M30.8 M
Slightly volatile
Capital Stock208.1 M323.8 M151 M
Slightly volatile

Profound Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.1 M1 M823.3 K
Slightly volatile
Interest Expense737.9 K693 K705.7 K
Very volatile
Selling General Administrative27.9 M26.6 M8.7 M
Slightly volatile
Other Operating Expenses25.7 M47.9 M20.5 M
Slightly volatile
Research Development10.8 M18.6 M8.7 M
Slightly volatile
Total Operating Expenses23.4 M43.9 M18.8 M
Slightly volatile
Interest Income2 M1.9 M1.1 M
Very volatile
Cost Of Revenue2.6 M4 M1.8 M
Slightly volatile
Selling And Marketing Expenses5.4 M10.9 M4.2 M
Slightly volatile
Reconciled Depreciation1.5 M1.1 M1.1 M
Slightly volatile

Profound Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation2.5 M3 M1.8 M
Slightly volatile
Begin Period Cash Flow29.5 M30.1 M21 M
Slightly volatile
Depreciation1.1 M1.1 M773.8 K
Slightly volatile
Other Non Cash Items218 K229.5 K2.5 M
Slightly volatile
Total Cash From Financing Activities66 M62.9 M21.8 M
Slightly volatile
End Period Cash Flow35.1 M63.1 M27.2 M
Slightly volatile
Sale Purchase Of Stock15.6 M10.4 M17.7 M
Slightly volatile
Change To Netincome4.6 M7.9 M4.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio29.0622.5426.6077
Slightly volatile
PTB Ratio3.893.983.9804
Slightly volatile
Days Sales Outstanding309277304
Slightly volatile
Book Value Per Share3.432.813.8688
Slightly volatile
Average Payables2.7 M2.6 M1.7 M
Slightly volatile
Stock Based Compensation To Revenue0.380.220.3715
Slightly volatile
Capex To Depreciation0.340.360.8116
Pretty Stable
PB Ratio3.893.983.9804
Slightly volatile
EV To Sales24.7418.3523.0726
Slightly volatile
Payables Turnover2.612.491.0398
Slightly volatile
Sales General And Administrative To Revenue1.631.461.3658
Slightly volatile
Research And Ddevelopement To Revenue2.411.832.0897
Very volatile
Capex To Revenue0.07540.09920.0833
Slightly volatile
Cash Per Share3.562.554.0509
Slightly volatile
Days Payables Outstanding1441521.6 K
Slightly volatile
Income Quality0.620.760.6655
Slightly volatile
Intangibles To Total Assets0.00410.00430.0524
Very volatile
Current Ratio8.399.4711.2085
Pretty Stable
Tangible Book Value Per Share3.152.793.6453
Slightly volatile
Receivables Turnover1.341.361.3964
Pretty Stable
Shareholders Equity Per Share3.432.813.8688
Slightly volatile
Debt To Equity0.09260.09750.7835
Slightly volatile
Capex Per Share0.03170.03330.115
Slightly volatile
Graham Net Net2.852.473.4721
Slightly volatile
Average Receivables3.9 M2.9 M3.6 M
Slightly volatile
Revenue Per Share0.420.50.4955
Slightly volatile
Interest Debt Per Share0.230.244.5171
Slightly volatile
Debt To Assets0.07970.08390.6698
Slightly volatile
Price Book Value Ratio3.893.983.9804
Slightly volatile
Days Of Payables Outstanding1441521.6 K
Slightly volatile
Ebt Per Ebit1.160.971.2342
Slightly volatile
Company Equity Multiplier1.61.341.3648
Pretty Stable
Long Term Debt To Capitalization0.05040.05310.296
Slightly volatile
Total Debt To Capitalization0.08540.08990.3288
Slightly volatile
Debt Equity Ratio0.09260.09750.7835
Slightly volatile
Quick Ratio7.828.6710.6634
Slightly volatile
Net Income Per E B T0.80.90.9919
Slightly volatile
Cash Ratio6.67.539.5395
Slightly volatile
Days Of Sales Outstanding309277304
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.131.181.0409
Slightly volatile
Price To Book Ratio3.893.983.9804
Slightly volatile
Fixed Asset Turnover12.2911.714.6607
Slightly volatile
Debt Ratio0.07970.08390.6698
Slightly volatile
Price Sales Ratio29.0622.5426.6077
Slightly volatile
Asset Turnover0.0960.140.1417
Slightly volatile
Gross Profit Margin0.390.590.444
Slightly volatile
Price Fair Value3.893.983.9804
Slightly volatile

Profound Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap313.8 M307.6 M223.9 M
Slightly volatile
Enterprise Value266.5 M250.4 M200.5 M
Slightly volatile

Profound Fundamental Market Drivers

Profound Upcoming Events

5th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
5th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Profound Medical Financial Statements

Profound Medical stakeholders use historical fundamental indicators, such as Profound Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Profound Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Profound Medical's assets and liabilities are reflected in the revenues and expenses on Profound Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Profound Medical Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue481.9 K391.7 K
Total Revenue11.7 M12.3 M
Cost Of Revenue4 M2.6 M
Stock Based Compensation To Revenue 0.22  0.38 
Sales General And Administrative To Revenue 1.46  1.63 
Research And Ddevelopement To Revenue 1.83  2.41 
Capex To Revenue 0.10  0.08 
Revenue Per Share 0.50  0.42 
Ebit Per Revenue(2.79)(2.93)

Currently Active Assets on Macroaxis

GOOGAlphabet Inc Class C
VVisa Class A
MSFTMicrosoft
GOOGAlphabet Inc Class C
GMGeneral Motors
When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:
How To Invest In Profound
Details
Is Profound Stock a good investment?
Details
What is Profound Medical's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Profound Medical Correlation against competitors.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profound Medical. If investors know Profound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Profound Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.32)
Revenue Per Share
0.492
Quarterly Revenue Growth
0.868
Return On Assets
(0.62)
Return On Equity
(1.24)
The market value of Profound Medical Corp is measured differently than its book value, which is the value of Profound that is recorded on the company's balance sheet. Investors also form their own opinion of Profound Medical's value that differs from its market value or its book value, called intrinsic value, which is Profound Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Profound Medical's market value can be influenced by many factors that don't directly affect Profound Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY